Ronald C Renaud Jr Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Ronald C Renaud Jr is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 31,500 shares of ATRA, which is worth approximately $242,865. The most recent transaction as insider was on Jun 23, 2022, when has been sold 20,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.5K

0% 3M change

0% 12M change

Total Value Held $242,865

Ronald C Renaud Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 23 2022	BUY Grant, award, or other acquisition	-	20,500 Added 39.42%	31,500 Common Stock
Jun 08 2021	BUY Grant, award, or other acquisition	-	11,000 Added 50.0%	11,000 Common Stock

Also insider at

TBIO

Translate Bio, Inc. Healthcare

Chief Executive Officer

IKNA

Ikena Oncology, Inc. Healthcare

Director

CERE

Cerevel Therapeutics Holdings, Inc. Healthcare

President & CEO

RCR